WO2021248793A1 - Method for screening ketosis-resistant molecular markers of dairy cows and application thereof - Google Patents

Method for screening ketosis-resistant molecular markers of dairy cows and application thereof Download PDF

Info

Publication number
WO2021248793A1
WO2021248793A1 PCT/CN2020/126281 CN2020126281W WO2021248793A1 WO 2021248793 A1 WO2021248793 A1 WO 2021248793A1 CN 2020126281 W CN2020126281 W CN 2020126281W WO 2021248793 A1 WO2021248793 A1 WO 2021248793A1
Authority
WO
WIPO (PCT)
Prior art keywords
ketosis
cows
analysis
resistance
dairy
Prior art date
Application number
PCT/CN2020/126281
Other languages
French (fr)
Chinese (zh)
Inventor
黄金明
白佳琛
鞠志花
姜强
王金鹏
张亚冉
王秀革
魏晓超
高亚平
杨春红
刘文浩
李荣岭
高运东
Original Assignee
山东省农业科学院奶牛研究中心
山东奥克斯畜牧种业有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 山东省农业科学院奶牛研究中心, 山东奥克斯畜牧种业有限公司 filed Critical 山东省农业科学院奶牛研究中心
Publication of WO2021248793A1 publication Critical patent/WO2021248793A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/124Animal traits, i.e. production traits, including athletic performance or the like
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Definitions

  • the invention belongs to the technical field of molecular genetic biology, and specifically relates to a method for screening a molecular marker for ketosis resistance in dairy cows and an application thereof.
  • Dairy cow ketosis is a metabolic disease caused by insufficient supply of carbohydrates such as sugars and volatile fatty acids to cause dysfunction of postpartum dairy cows. It mostly occurs in high-yielding dairy cows with good lactation performance (Hibbitt 1979). Ketosis is one of the most common and expensive metabolic diseases in dairy farms, with a prevalence of approximately 30%-40% (Zhang and Ametaj, 2017). Cows suffering from ketosis have reduced milk production, reproductive performance and immunity, and are at higher risk of other perinatal diseases (McArt et al., 2013).
  • Ketosis is characterized by increased levels of ketone bodies in milk, urine, and blood of cows. Clinically, acetoacetate, ⁇ -hydroxybutyric acid (BHBA) and acetone are collectively referred to as ketone bodies. Beta-hydroxybutyric acid is the most common ketone body for diagnosing ketosis in dairy cows (Oetzel, 2004). Plasma ⁇ -hydroxybutyric acid concentration ⁇ 1.2mmol/L is the gold standard for judging whether cows are suffering from ketosis (McArt et al., 2011).
  • Dairy cows are resistant to ketosis, and there are large differences between individuals.
  • the inventor found that the heritability of ketosis resistance is low, about 0.02-0.16. It is extremely difficult to rely on phenotypic conventional breeding methods for selection, and molecular breeding strategies have more advantages for traits with low heritability and can be very good. Solve this problem (Koeck et al., 2012; Koeck et al., 2014). Foreign researchers have also regarded ketosis resistance as a hot trait in dairy cattle breeding and have begun to pay attention (Kroezen et al., 2018; Parker Gaddis et al., 2018). Therefore, further mining the functional genes and markers that affect the formation of ketosis resistance in dairy cows and clarifying their molecular regulation mechanisms are of great significance and value for the molecular breeding of high ketosis resistant cattle.
  • the present invention provides a method and application for screening bovine ketosis resistance molecular markers.
  • the present invention aims at the genetic characteristics of Chinese Holstein dairy cows’ ketosis, from the perspective of genome evolution and selection and disease susceptibility.
  • the cattle 150K gene chip to sequence the blood samples of ketosis and healthy Chinese Holstein dairy cows, and integrate the Fst, XPEHH, and XPCLR three genomic selection signal analysis methods as well as the GEMMA and PLINK whole-genome association analysis methods, and successfully screened dairy cows
  • the ketosis resistance gene and its molecular markers, and the establishment of corresponding detection methods have good practical application value.
  • the present invention relates to the following technical solutions:
  • the first aspect of the present invention provides a method for screening a molecular marker for ketosis resistance in dairy cows, the method at least comprising:
  • the present invention screened and identified the APOA1 gene as a key gene for ketosis resistance in dairy cows, and therefore can be used as a molecular marker for ketosis resistance in dairy cows; furthermore, molecular markers for ketosis resistance in dairy cows also include A single nucleotide polymorphism in the gene: g.-572A>G.
  • concentration of ⁇ -hydroxybutyric acid in the blood of GG type cows with APOA1 gene is significantly lower than that of AA genotype.
  • the luciferase activity test showed that the promoter activity of APOA1 gene GG type was significantly higher than that of AA type individuals. Therefore, the APAO1 gene core promoter polymorphism site g.-572A>G can be used to evaluate the resistance of cattle to ketosis.
  • the dairy cow is a Chinese Holstein dairy cow.
  • the second aspect of the present invention provides the application of the above method in any of the following 1)-9):
  • the dairy cow is a Chinese Holstein dairy cow.
  • the application mode includes:
  • the molecule is labeled g.-572A>G.
  • the above technical solution provides a single nucleotide polymorphism in the APOA1 gene that is related to ketosis resistance. By detecting the genotype of the locus, the ketosis resistance can be easily evaluated. The ketosis resistance provides an effective basis for evaluation and saves economic costs for livestock breeding enterprises.
  • the reagents used to detect the APOA1 gene, the reagents used to detect the single nucleotide polymorphism site of the APOA1 gene and the primers can be used to prepare a kit for the detection of ketosis resistance in dairy cows. , Provides a convenient product for ketosis resistance in dairy cows, so it has good practical application value.
  • Figure 1 is a flow chart of the method for screening molecular markers for ketosis resistance in dairy cows in Example 1 of the present invention
  • Fig. 2 shows the molecular marker APOA1 gene for dairy cow ketosis resistance screened by XPCLR forward selection signal analysis and PLINK whole genome association analysis in Example 1 of the present invention; where A is XPCLR forward selection signal analysis; B is PLINK whole genome Correlation Analysis;
  • Figure 3 is a schematic diagram of the APOA1 gene and its genome structure in Example 2 of the present invention, and the position information of SNP g.-572A>G in the genome.
  • Figure 4 shows the activity of promoters of different genotypes in the APOA1 gene in Example 3 of the present invention.
  • the design idea of the present invention is as follows: firstly, the candidate genes for ketosis resistance in dairy cows are screened through methods such as gene chip sequencing and whole gene association analysis. Secondly, the ketosis resistance candidate gene APOA1 was quantitatively analyzed, and the g.-572A>G site was identified in the core promoter region. Third, the concentration of ⁇ -hydroxybutyric acid in the blood of dairy cows with GG genotype at this locus was significantly lower than that of AA genotype, and the luciferase activity of the promoter of GG type was significantly higher than that of individuals of type AA, suggesting that the APOA1 gene is more abundant. The status g.-572A>G can be used as a marker for evaluating the resistance of dairy cows to ketosis.
  • a method for screening dairy cows for ketosis resistance genes the method at least comprising:
  • the dairy cow is a Chinese Holstein dairy cow.
  • the method for screening dairy cows for ketosis resistance genes includes:
  • steps S4 and S5 are in no order.
  • step S1 includes:
  • S1.2 Collect blood from healthy cows and cows suffering from ketosis, and extract DNA from blood tissues.
  • step S2 includes:
  • S2.5 uses the 150K gene chip as a reference to fill in the genotype of the 50K gene chip data.
  • step S3 includes:
  • step S4 includes:
  • S4.1 uses GEMMA univariate linear mixed model, and conducts genome-wide association analysis with ketosis or healthy binary traits of dairy cows as the phenotype;
  • S4.5 SNP annotations are retrieved in the UCSC database through Bedtools.
  • step S5 includes:
  • step S6 includes:
  • the cow ketosis resistance candidate gene includes APOA1; the SNP locus is g.-572A>G.
  • the site naming rules are as follows: the A base of the first ATG (translation initiation codon) of the APOA1 gene (NCBI: AC_000172.1) is named +1, and the downstream direction is +2, +3... ..., the upstream direction is -1, -2..., and the sites are respectively located at -572 in the upstream direction of the APOA1 gene.
  • the dairy cow is a Chinese Holstein dairy cow.
  • the application mode includes:
  • the molecular label is g.-572A>G;
  • the primers for amplifying gene fragments containing molecular markers include SEQ ID NO.1 and SEQ ID NO.2.
  • the blood is collected from the caudal vein of the cow, and the principle of vacuum negative pressure anticoagulation is used to collect the blood of the cow into a 5ml vacuum blood collection tube.
  • the blood ketone meter was used to measure the concentration of ⁇ -hydroxybutyric acid in the blood of 190 cows, and a drop of blood from the cows at the early stage of milk production was dripped onto the chip test strip matched with the blood ketone meter. , Insert the blood ketone meter, wait for 10 seconds for the analysis and calculation of the instrument, read and record the concentration of ⁇ -hydroxybutyric acid in the blood, and repeat the measurement experiment twice.
  • the blood cards of 190 cattle blood DNA samples qualified and titrated were sent to the gene chip sequencing company, and the DNA of 190 cattle was genotyped and data assembled using the American Illumina Bovine 150K gene chip to obtain genotype data.
  • ketosis-related gene chip data containing 2488 cattle and 50K SNP from the NAGRP database.
  • the 50K gene chip of 2488 cattle in the NAGRP database was used for genotype filling.
  • the ketosis group was used as the reference group, and the healthy group was used as the experimental group, that is, the positive selection group.
  • Three methods suitable for disease-control positive selection signal analysis: Fst, XPEHH, and XPCLR are used for selection signal analysis.
  • R 5'-GCACCCTCTACTCACTCCAT-3' (SEQ ID NO. 2).
  • a 647bp promoter fragment of the APOA1 gene was amplified, and promoter fragments with genotypes of GG and AA were selected to construct pGL3-basic-GG and The promoter vector of pGL3-basic-AA type was transfected into HepG2 cells, and its luciferase activity was measured.
  • the results showed that the luciferase activity of the GG type promoter of APOA1 gene was significantly higher than that of the AA type individual (P ⁇ 0.05).

Abstract

Provided are a method for screening ketosis-resistant molecular markers of dairy cows and an application thereof, which belong to the technical field of molecular genetic biology. Taking healthy and ketosis dairy cows as samples, chip sequencing, data filling, selection signal analysis, and whole-genome association analysis, and the like are performed to screen out a key gene APOA1 that affects the resistance of Chinese Holstein cattle to ketosis. The single nucleotide polymorphism site g.-572A>G is obtained by screening in the APOA1 gene promoter region. By means of association analysis, promoter activity analysis and other methods, it is obtained that the concentration of β-hydroxybutyric acid in the blood of GG genotype dairy cows is significantly lower than that of the AA genotype, and the promoter activity of GG genotype individuals is significantly higher than that of AA genotype individuals. By using the technical solution, genotyping the APOA1 gene promoter region site g.-572A>G may screen out dairy cow individuals that have strong ketosis resistance, thus achieving the purpose of saving on breeding costs.

Description

一种筛选奶牛酮病抗性分子标记的方法及其应用Method for screening dairy cow ketosis resistance molecular markers and application thereof 技术领域Technical field
本发明属于分子遗传生物技术领域,具体涉及一种筛选奶牛酮病抗性分子标记的方法及其应用。The invention belongs to the technical field of molecular genetic biology, and specifically relates to a method for screening a molecular marker for ketosis resistance in dairy cows and an application thereof.
背景技术Background technique
公开该背景技术部分的信息仅仅旨在增加对本发明的总体背景的理解,而不必然被视为承认或以任何形式暗示该信息构成已经成为本领域一般技术人员所公知的现有技术。Disclosure of the background information is only intended to increase the understanding of the overall background of the present invention, and is not necessarily regarded as an acknowledgement or any form of suggestion that the information constitutes the prior art known to those of ordinary skill in the art.
近几十年来,奶业集约化饲养程度不断加强,并一味追求高产,奶牛产后疾病日趋突出。奶牛酮病是由糖类等碳水化合物及挥发性脂肪酸供应不足引发产后奶牛功能失调的代谢性疾病,多发生于泌乳性能良好的高产奶牛(Hibbitt 1979)。酮病是奶牛场最常见和最昂贵的代谢疾病之一,患病率大约为30%-40%(Zhang and Ametaj,2017)。患有酮病的奶牛其产奶量、生殖性能和免疫能力降低,罹患其他围产期疾病的风险也更高(McArt et al.,2013)。Duffield指出一例酮病牛的综合各项损失在50到100美元之间(Duffield,2000)。酮病的特征是奶牛乳、尿、血液中的酮体含量增高,临床上乙酰乙酸、β-羟丁酸(BHBA)、丙酮这三种物质总称为酮体。β-羟丁酸是诊断奶牛酮病的最常见酮体(Oetzel,2004)。血浆β-羟丁酸浓度≥1.2mmol/L是判断奶牛是否患酮病的金标准(McArt et al.,2011)。In recent decades, the degree of intensive feeding in the dairy industry has continued to increase, and the pursuit of high yields has led to increasingly prominent postpartum diseases in dairy cows. Dairy cow ketosis is a metabolic disease caused by insufficient supply of carbohydrates such as sugars and volatile fatty acids to cause dysfunction of postpartum dairy cows. It mostly occurs in high-yielding dairy cows with good lactation performance (Hibbitt 1979). Ketosis is one of the most common and expensive metabolic diseases in dairy farms, with a prevalence of approximately 30%-40% (Zhang and Ametaj, 2017). Cows suffering from ketosis have reduced milk production, reproductive performance and immunity, and are at higher risk of other perinatal diseases (McArt et al., 2013). Duffield pointed out that the combined losses of a case of ketosis cattle ranged from 50 to 100 US dollars (Duffield, 2000). Ketosis is characterized by increased levels of ketone bodies in milk, urine, and blood of cows. Clinically, acetoacetate, β-hydroxybutyric acid (BHBA) and acetone are collectively referred to as ketone bodies. Beta-hydroxybutyric acid is the most common ketone body for diagnosing ketosis in dairy cows (Oetzel, 2004). Plasma β-hydroxybutyric acid concentration ≥1.2mmol/L is the gold standard for judging whether cows are suffering from ketosis (McArt et al., 2011).
奶牛对酮病具有抗性,且个体间存在较大差异。发明人发现,酮病抗性的遗传力低,约为0.02-0.16,若依赖表型的常规育种方法进行选择,难度极大,而分子育种策略对于低遗传力性状更具优势,可以很好地解决这个问题 (Koeck et al.,2012;Koeck et al.,2014)。国外研究者也将酮病抗性作为奶牛育种的热点性状,并开始投入关注(Kroezen et al.,2018;Parker Gaddis et al.,2018)。因此,进一步挖掘影响奶牛酮病抗性形成的功能基因和标记并阐明其分子调控机制,对于高酮病抗性牛的分子育种具有重要意义和价值。Dairy cows are resistant to ketosis, and there are large differences between individuals. The inventor found that the heritability of ketosis resistance is low, about 0.02-0.16. It is extremely difficult to rely on phenotypic conventional breeding methods for selection, and molecular breeding strategies have more advantages for traits with low heritability and can be very good. Solve this problem (Koeck et al., 2012; Koeck et al., 2014). Foreign researchers have also regarded ketosis resistance as a hot trait in dairy cattle breeding and have begun to pay attention (Kroezen et al., 2018; Parker Gaddis et al., 2018). Therefore, further mining the functional genes and markers that affect the formation of ketosis resistance in dairy cows and clarifying their molecular regulation mechanisms are of great significance and value for the molecular breeding of high ketosis resistant cattle.
发明内容Summary of the invention
针对上述现有技术,本发明提供一种筛选牛酮病抗性分子标记的方法及其应用,本发明针对中国荷斯坦奶牛酮病发生过程的遗传特性,从基因组进化和选择以及疾病易感性角度考虑,采用牛150K基因芯片对患酮病和健康中国荷斯坦奶牛血液样本进行测序,同时整合Fst、XPEHH、XPCLR三种基因组选择信号分析方法以及GEMMA、PLINK全基因组关联分析方法,成功筛选出奶牛酮病抗性基因及其分子标记,并建立相应检测方法,因此具有良好的实际应用之价值。In view of the above-mentioned prior art, the present invention provides a method and application for screening bovine ketosis resistance molecular markers. The present invention aims at the genetic characteristics of Chinese Holstein dairy cows’ ketosis, from the perspective of genome evolution and selection and disease susceptibility. Consider using the cattle 150K gene chip to sequence the blood samples of ketosis and healthy Chinese Holstein dairy cows, and integrate the Fst, XPEHH, and XPCLR three genomic selection signal analysis methods as well as the GEMMA and PLINK whole-genome association analysis methods, and successfully screened dairy cows The ketosis resistance gene and its molecular markers, and the establishment of corresponding detection methods, have good practical application value.
为实现上述目的,本发明涉及以下技术方案:In order to achieve the above objectives, the present invention relates to the following technical solutions:
本发明的第一个方面,提供一种筛选奶牛酮病抗性分子标记的方法,所述方法至少包括:The first aspect of the present invention provides a method for screening a molecular marker for ketosis resistance in dairy cows, the method at least comprising:
基于SNP芯片检测分析健康和患酮病奶牛DNA样品;Analyze DNA samples of healthy and ketotic cows based on SNP chip detection;
基于Fst、XPEHH和XPCLR基因组选择信号分析方法和GEMMA、PLINK全基因组关联分析方法进行分析;筛选受到显著正选择和与酮病显著相关的单核苷酸多态SNPs及候选基因,整合基因功能注释筛选酮病抗性的SNP分子标记。Analysis based on Fst, XPEHH and XPCLR genome selection signal analysis methods and GEMMA and PLINK genome-wide association analysis methods; screening SNPs and candidate genes that are significantly positively selected and significantly associated with ketosis, and integrate gene function annotations Screen SNP molecular markers for ketosis resistance.
进一步的,基于上述方法,本发明筛选鉴定出APOA1基因为奶牛酮病抗性的关键基因,因此可作为奶牛酮病抗性分子标记;更进一步的,奶牛酮病抗性分子标记还包括位于该基因上1个单核苷酸多态位点:g.-572A>G。 经试验证明,APOA1基因GG型奶牛血液中β-羟丁酸浓度显著低于AA基因型。并且荧光素酶活性检测,APOA1基因GG型的启动子活性显著高于AA型个体的启动子活性。因此APAO1基因核心启动子多态性位点g.-572A>G可实现对牛的酮病抗性进行评估。Further, based on the above method, the present invention screened and identified the APOA1 gene as a key gene for ketosis resistance in dairy cows, and therefore can be used as a molecular marker for ketosis resistance in dairy cows; furthermore, molecular markers for ketosis resistance in dairy cows also include A single nucleotide polymorphism in the gene: g.-572A>G. Experiments have shown that the concentration of β-hydroxybutyric acid in the blood of GG type cows with APOA1 gene is significantly lower than that of AA genotype. And the luciferase activity test showed that the promoter activity of APOA1 gene GG type was significantly higher than that of AA type individuals. Therefore, the APAO1 gene core promoter polymorphism site g.-572A>G can be used to evaluate the resistance of cattle to ketosis.
其中,所述奶牛为中国荷斯坦奶牛。Wherein, the dairy cow is a Chinese Holstein dairy cow.
本发明的第二个方面,提供上述方法在如下1)-9)中任一种中的应用:The second aspect of the present invention provides the application of the above method in any of the following 1)-9):
1)鉴定或辅助鉴定待测奶牛的酮病抗性;1) Identify or assist in the identification of ketosis resistance of the cows to be tested;
2)制备鉴定或辅助鉴定待测奶牛的酮病抗性的产品;2) Preparation of products to identify or assist in identifying the ketosis resistance of the cows to be tested;
3)鉴定或辅助鉴定待测奶牛为酮病抗性奶牛;3) Identify or assist in identifying the cows to be tested as ketosis-resistant cows;
4)制备鉴定或辅助鉴定待测奶牛为酮病抗性奶牛的产品;4) Preparation of products to identify or assist in identifying the cows to be tested as ketosis-resistant cows;
5)奶牛选育;5) Breeding of dairy cows;
6)选育奶牛酮病抗性品种;6) Breeding breeds resistant to ketosis in dairy cows;
7)制备选育奶牛酮病抗性品种的产品;7) Preparation of products for breeding ketosis-resistant varieties of dairy cows;
8)鉴定或辅助鉴定待测奶牛的酮病抗性性状;8) Identify or assist in identifying the ketosis resistance traits of the cows to be tested;
9)制备鉴定或辅助鉴定奶牛的酮病抗性性状的产品。9) Preparation of products for identifying or assisting in identifying traits of ketosis resistance in dairy cows.
其中,所述奶牛为中国荷斯坦奶牛。Wherein, the dairy cow is a Chinese Holstein dairy cow.
本发明的又一具体实施方式中,所述应用方式包括:In another specific implementation manner of the present invention, the application mode includes:
提取不同奶牛个体的血液DNA;Extract blood DNA from different individual cows;
鉴定带有酮病抗性分子标记的个体。Identify individuals with molecular markers of ketosis resistance.
所述分子标记为g.-572A>G。The molecule is labeled g.-572A>G.
与现有技术相比,上述技术方案的有益效果是:Compared with the prior art, the beneficial effects of the above technical solution are:
1)上述技术方案的检测方法具有独创性,针对牛酮病发生过程的遗传 特性,从基因组进化和选择以及疾病易感性角度,以患酮病牛群组作为参考组,健康牛群组作为实验组,整合多种基因组正向选择信号分析技术,分别以奶牛患酮病或健康二元性状为表型以及以奶牛血液中β-羟丁酸含量作为表型,采用全基因组关联分析方法和策略,高效准确筛选与牛酮病发生相关的关键基因和分子标记,方法设计合理,依据关键基因和标记设计的检测方法,具有准确性高、应用操作简便的特点;1) The detection method of the above-mentioned technical scheme is original. According to the genetic characteristics of the occurrence of bovine ketosis, from the perspective of genome evolution and selection and disease susceptibility, the group of ketosis cattle is used as the reference group, and the healthy cattle group is used as the experiment. Group, integrating multiple genomic positive selection signal analysis techniques, using ketosis or healthy binary traits in dairy cows as the phenotype and β-hydroxybutyric acid content in the blood of dairy cows as the phenotype, using genome-wide association analysis methods and strategies , Efficient and accurate screening of key genes and molecular markers related to the occurrence of bovine ketosis, the method design is reasonable, and the detection method designed based on the key genes and markers has the characteristics of high accuracy and simple application and operation;
2)上述技术方案提供了APOA1基因中与酮病抗性相关的一个单核苷酸多态位点,通过检测所述位点的基因型,可以方便的对酮病抗性进行评价,为奶牛的酮病抗性提供有效的评价依据,为家畜养殖企业节省经济成本。2) The above technical solution provides a single nucleotide polymorphism in the APOA1 gene that is related to ketosis resistance. By detecting the genotype of the locus, the ketosis resistance can be easily evaluated. The ketosis resistance provides an effective basis for evaluation and saves economic costs for livestock breeding enterprises.
3)基于上述基因及位点表达差异的确认,用于检测APOA1基因的试剂、用于检测APOA1基因单核苷酸多态位点的试剂及引物可用于制备奶牛酮病抗性检测的试剂盒,为奶牛酮病抗性提供使用便利的产品,因此具有良好的实际应用之价值。3) Based on the confirmation of the expression differences of the above genes and sites, the reagents used to detect the APOA1 gene, the reagents used to detect the single nucleotide polymorphism site of the APOA1 gene and the primers can be used to prepare a kit for the detection of ketosis resistance in dairy cows. , Provides a convenient product for ketosis resistance in dairy cows, so it has good practical application value.
附图说明Description of the drawings
构成本发明的一部分的说明书附图用来提供对本发明的进一步理解,本发明的示意性实施例及其说明用于解释本公开,并不构成对本公开的不当限定。The accompanying drawings of the specification constituting a part of the present invention are used to provide a further understanding of the present invention, and the exemplary embodiments and descriptions of the present invention are used to explain the present disclosure, and do not constitute an improper limitation of the present disclosure.
图1为本发明实施例1中筛选奶牛酮病抗性分子标记的方法流程图;Figure 1 is a flow chart of the method for screening molecular markers for ketosis resistance in dairy cows in Example 1 of the present invention;
图2为本发明实施例1中采用XPCLR正向选择信号分析和PLINK全基因组关联分析筛选到奶牛酮病抗性分子标记APOA1基因;其中,A为XPCLR正向选择信号分析;B为PLINK全基因组关联分析;Fig. 2 shows the molecular marker APOA1 gene for dairy cow ketosis resistance screened by XPCLR forward selection signal analysis and PLINK whole genome association analysis in Example 1 of the present invention; where A is XPCLR forward selection signal analysis; B is PLINK whole genome Correlation Analysis;
图3为本发明实施例2中APOA1基因及其基因组结构示意图,以及SNP g.-572A>G在基因组中位置信息。Figure 3 is a schematic diagram of the APOA1 gene and its genome structure in Example 2 of the present invention, and the position information of SNP g.-572A>G in the genome.
图4为本发明实施例3中APOA1基因中不同基因型的启动子的活性。Figure 4 shows the activity of promoters of different genotypes in the APOA1 gene in Example 3 of the present invention.
具体实施方式detailed description
应该指出,以下详细说明都是例示性的,旨在对本申请提供进一步的说明。除非另有指明,本文使用的所有技术和科学术语具有与本申请所属技术领域的普通技术人员通常理解的相同含义。It should be pointed out that the following detailed descriptions are all illustrative and are intended to provide further explanations for the application. Unless otherwise specified, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the technical field to which this application belongs.
需要注意的是,这里所使用的术语仅是为了描述具体实施方式,而非意图限制根据本申请的示例性实施方式。如在这里所使用的,除非上下文另外明确指出,否则单数形式也意图包括复数形式,此外,还应当理解的是,当在本说明书中使用术语“包含”和/或“包括”时,其指明存在特征、步骤、操作、器件、组件和/或它们的组合。It should be noted that the terms used here are only for describing specific embodiments, and are not intended to limit the exemplary embodiments according to the present application. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should also be understood that when the terms "comprising" and/or "including" are used in this specification, they indicate There are features, steps, operations, devices, components, and/or combinations thereof.
正如背景技术所介绍的,发明人在研究中发现牛虽然具有相似的遗传背景,其血液中β-羟基丁酸含量的表型以及患酮病与否却存在显著的差异,推测其性状差异可能与基因的单核苷酸多态性相关。As described in the background art, the inventors found that although cattle have similar genetic backgrounds, there are significant differences in the phenotypes of β-hydroxybutyric acid content in their blood and whether they suffer from ketosis. It is speculated that their traits may be different. It is related to the single nucleotide polymorphism of the gene.
本发明的设计思路为:首先,通过基因芯片测序以及全基因关联分析等方法,筛选出奶牛酮病抗性候选基因。其次,对酮病抗性候选基因APOA1进行定量分析,在核心启动子区鉴定出g.-572A>G位点。再次,该位点GG基因型奶牛血液中β-羟丁酸浓度显著低于AA基因型,并且GG型的启动子荧光素酶活性显著高于AA型个体的启动子活性,启示了APOA1基因多态位点g.-572A>G可作为评价奶牛酮病抗性的标志物。The design idea of the present invention is as follows: firstly, the candidate genes for ketosis resistance in dairy cows are screened through methods such as gene chip sequencing and whole gene association analysis. Secondly, the ketosis resistance candidate gene APOA1 was quantitatively analyzed, and the g.-572A>G site was identified in the core promoter region. Third, the concentration of β-hydroxybutyric acid in the blood of dairy cows with GG genotype at this locus was significantly lower than that of AA genotype, and the luciferase activity of the promoter of GG type was significantly higher than that of individuals of type AA, suggesting that the APOA1 gene is more abundant. The status g.-572A>G can be used as a marker for evaluating the resistance of dairy cows to ketosis.
本发明的一个具体实施方式中,提供一种筛选奶牛酮病抗性基因的方法,所述方法至少包括:In a specific embodiment of the present invention, there is provided a method for screening dairy cows for ketosis resistance genes, the method at least comprising:
基于SNP芯片检测分析健康奶牛和患酮病奶牛DNA样品;Analyze DNA samples of healthy cows and cows suffering from ketosis based on SNP chip detection;
基于Fst、XPCLR和XPEHH基因组选择信号分析方法和GEMMA、PLINK全基因组关联分析方法进行分析;筛选受到显著正选择和与酮病显著相关的单核苷酸多态SNPs以及候选基因,整合基因功能注释筛选酮病抗性的SNP分子标记。Analysis based on Fst, XPCLR and XPEHH genome selection signal analysis methods and GEMMA and PLINK genome-wide association analysis methods; screening SNPs and candidate genes that are significantly positively selected and significantly related to ketosis, and integrate gene function annotations Screen SNP molecular markers for ketosis resistance.
其中,所述奶牛为中国荷斯坦奶牛。Wherein, the dairy cow is a Chinese Holstein dairy cow.
本发明的又一具体实施方式中,所述筛选奶牛酮病抗性基因方法包括:In another specific embodiment of the present invention, the method for screening dairy cows for ketosis resistance genes includes:
S1.健康奶牛和患酮病奶牛样品的采集及DNA提取;S1. Collection and DNA extraction of samples from healthy cows and cows suffering from ketosis;
S2.SNP芯片检测分析;S2. SNP chip detection and analysis;
S3.基因型填充;S3. Genotype filling;
S4.Fst、XPCLR、XPEHH基因组选择信号分析;S4. Fst, XPCLR, XPEHH genome selection signal analysis;
S5.GEMMA、PLINK全基因组关联分析;S5. GEMMA, PLINK genome-wide association analysis;
S6.基于候选基因的筛选策略筛选候选基因;S6. Screening candidate genes based on the screening strategy of candidate genes;
S7.鉴定位于候选基因内受选择的SNPs;S7. Identify selected SNPs located in candidate genes;
其中,步骤S4与S5没有先后顺序之分。Among them, steps S4 and S5 are in no order.
本发明的又一具体实施方式中,步骤S1具体方法包括:In another specific embodiment of the present invention, the specific method of step S1 includes:
S1.1对奶牛血液中β-羟丁酸浓度进行测定;S1.1 Determine the concentration of β-hydroxybutyric acid in the blood of dairy cows;
S1.2采集健康奶牛和患酮病奶牛的血液,提取血液组织中的DNA。S1.2 Collect blood from healthy cows and cows suffering from ketosis, and extract DNA from blood tissues.
本发明的又一具体实施方式中,步骤S2具体方法包括:In another specific embodiment of the present invention, the specific method of step S2 includes:
S2.1使用SNP芯片对DNA样品进行分析,并进行基因分型;S2.1 Use SNP chips to analyze DNA samples and perform genotyping;
S2.2对SNP数据进行过滤,对剩余符合要求的SNP做进一步分析;S2.2 Filter the SNP data, and further analyze the remaining SNPs that meet the requirements;
S2.3为每条染色体构建单倍型;S2.3 constructs a haplotype for each chromosome;
S2.4获取数据库中50K基因芯片数据;S2.4 Obtain 50K gene chip data in the database;
S2.5以150K基因芯片为参考,对50K基因芯片数据进行基因型填充。S2.5 uses the 150K gene chip as a reference to fill in the genotype of the 50K gene chip data.
本发明的又一具体实施方式中,步骤S3具体方法包括:In another specific embodiment of the present invention, the specific method of step S3 includes:
S3.1选择信号Fst和hapFLK基因组扫描和局部进化树的构建:对奶牛品种获得的所有数据进行Fst分析;S3.1 Selection signal Fst and hapFLK genome scanning and local evolutionary tree construction: Fst analysis of all data obtained by dairy cow breeds;
S3.2估算患酮病奶牛和健康奶牛品种之间的XPCLR值;S3.2 Estimate the XPCLR value between ketosis cows and healthy cow breeds;
S3.3估算患酮病奶牛和健康奶牛品种之间的XPEHH值。S3.3 Estimate the XPEHH value between ketosis cows and healthy cow breeds.
本发明的又一具体实施方式中,步骤S4具体方法包括:In another specific embodiment of the present invention, the specific method of step S4 includes:
S4.1采用GEMMA单变量线性混合模型,以奶牛患酮病或健康二元性状为表型进行全基因组关联分析;S4.1 uses GEMMA univariate linear mixed model, and conducts genome-wide association analysis with ketosis or healthy binary traits of dairy cows as the phenotype;
S4.2以奶牛血液中β-羟丁酸含量作为表型,利用多元回归模型,以奶牛的胎次、年龄为协变量进行全基因组关联分析;S4.2 Take the content of β-hydroxybutyric acid in the blood of dairy cows as the phenotype, use a multiple regression model, and use the parity and age of dairy cows as covariates to perform genome-wide association analysis;
S4.3基于Benjamini和Hochberg校正方法计算显著性的P值;S4.3 Calculate the significance P value based on the Benjamini and Hochberg correction method;
S4.4生成GWAS分析的曼哈顿图;S4.4 Generate Manhattan chart of GWAS analysis;
S4.5 SNP注释通过Bedtools在UCSC数据库中检索。S4.5 SNP annotations are retrieved in the UCSC database through Bedtools.
本发明的又一具体实施方式中,步骤S5具体方法包括:In another specific embodiment of the present invention, the specific method of step S5 includes:
S5.1选择具有Fst、XPCLR或XPEHH中有强选择信号和最显著P值的SNPs;S5.1 Select SNPs with strong selection signal and the most significant P value among Fst, XPCLR or XPEHH;
S5.2使用UCSC基因组浏览器检索由SNP定义的每个选定区域内的带注释的Refseq基因;S5.2 Use the UCSC genome browser to retrieve the annotated Refseq genes in each selected region defined by the SNP;
S5.3选用每种分析方法所得出的信号值排名前1%的SNP标记定位受选择的SNPs,将基因限定在每个显著SNP上下游500K bp以内,定位受正 选择的基因;筛选出同时在至少有2种分析方法同时鉴定到的基因,并且至少在一种分析方法中,其选择信号值或者显著性检验的P值排名前10,作为重要候选基因;S5.3 Select the top 1% SNP markers with the signal value obtained by each analysis method to locate the selected SNPs, limit the genes to within 500K bp upstream and downstream of each significant SNP, locate the positively selected genes; screen out simultaneous Genes identified by at least two analysis methods at the same time, and in at least one analysis method, the selected signal value or the P value of the significance test ranks the top 10 as important candidate genes;
S5.4应用DVAID对筛选到的候选基因进行功能分析,并应用Benjamini-Hochberg进行多重校正,分析基因富集在哪些特定的分子功能以及细胞成分或者生物学通路中。S5.4 Use DVAID to perform functional analysis on the selected candidate genes, and apply Benjamini-Hochberg to perform multiple corrections to analyze which specific molecular functions and cellular components or biological pathways are enriched in.
本发明的又一具体实施方式中,步骤S6具体方法包括:In another specific embodiment of the present invention, the specific method of step S6 includes:
S6.1确定候选基因,鉴定出位于候选基因受选择的SNPs;S6.1 Determine candidate genes and identify SNPs located in candidate genes that are selected;
S6.2对鉴定出的SNPs与奶牛酮病做相关性分析。S6.2 Perform correlation analysis on the identified SNPs and ketosis in dairy cows.
本发明的又一具体实施方式中,所述奶牛酮病抗性候选基因包括APOA1;SNP位点为g.-572A>G。In another specific embodiment of the present invention, the cow ketosis resistance candidate gene includes APOA1; the SNP locus is g.-572A>G.
其中,所述位点命名规则如下:将APOA1基因(NCBI:AC_000172.1)第一个ATG(翻译起始密码子)的A碱基命名为+1,下游方向依次为+2、+3……,上游方向依次为-1、-2……,所述位点分别位于APOA1基因上游方向-572处。The site naming rules are as follows: the A base of the first ATG (translation initiation codon) of the APOA1 gene (NCBI: AC_000172.1) is named +1, and the downstream direction is +2, +3... ..., the upstream direction is -1, -2..., and the sites are respectively located at -572 in the upstream direction of the APOA1 gene.
本发明的又一具体实施方式中,提供上述方法在如下1)-9)中任一种中的应用:In another specific embodiment of the present invention, the application of the above method in any of the following 1)-9) is provided:
1)鉴定或辅助鉴定待测奶牛的酮病抗性;1) Identify or assist in the identification of ketosis resistance of the cows to be tested;
2)制备鉴定或辅助鉴定待测奶牛的酮病抗性的产品;2) Preparation of products to identify or assist in identifying the ketosis resistance of the cows to be tested;
3)鉴定或辅助鉴定待测奶牛为酮病抗性奶牛;3) Identify or assist in identifying the cows to be tested as ketosis-resistant cows;
4)制备鉴定或辅助鉴定待测奶牛为酮病抗性奶牛的产品;4) Preparation of products to identify or assist in identifying the cows to be tested as ketosis-resistant cows;
5)奶牛选育;5) Breeding of dairy cows;
6)选育奶牛酮病抗性品种;6) Breeding ketosis-resistant breeds of dairy cows;
7)制备选育奶牛酮病抗性品种的产品;7) Preparation of products for breeding ketosis-resistant varieties of dairy cows;
8)鉴定或辅助鉴定待测奶牛的酮病抗性性状;8) Identify or assist in identifying the ketosis resistance traits of the cows to be tested;
9)制备鉴定或辅助鉴定奶牛的酮病抗性性状的产品。9) Preparation of products for identifying or assisting in identifying traits of ketosis resistance in dairy cows.
其中,所述奶牛为中国荷斯坦奶牛。Wherein, the dairy cow is a Chinese Holstein dairy cow.
本发明的又一具体实施方式中,所述应用方式包括:In another specific implementation manner of the present invention, the application mode includes:
提取不同奶牛个体的血液DNA;Extract blood DNA from different individual cows;
鉴定带有酮病抗性分子标记的个体。Identify individuals with molecular markers of ketosis resistance.
所述分子标记为g.-572A>G;The molecular label is g.-572A>G;
扩增含分子标记基因片段的引物包括SEQ ID NO.1和SEQ ID NO.2。The primers for amplifying gene fragments containing molecular markers include SEQ ID NO.1 and SEQ ID NO.2.
下面结合实施例对本发明内容作进一步的说明,但不是对本发明的限定。应理解这些实施例仅用于说明本发明而不用于限制本发明的范围。下列实施例中未注明具体条件的试验方法,通常按照常规条件进行。The content of the present invention will be further described below in conjunction with the embodiments, but it is not a limitation of the present invention. It should be understood that these examples are only used to illustrate the present invention and not to limit the scope of the present invention. The test methods without specific conditions in the following examples are usually carried out in accordance with conventional conditions.
实施例1 牛酮病抗性候选基因的筛选Example 1 Screening of Candidate Genes for Bovine Ketosis Resistance
1.中国荷斯坦奶牛血液样品的采集1. Collection of blood samples from Chinese Holstein cows
对山东省DHI数据库中的牛进行前期筛选,选取了DHI信息完备,95头患酮病的牛和95头健康牛,共计190头,这190头牛的年龄、胎次分布均匀,并且在过去的泌乳期7到14天内,至少有两个泌乳期报告患有酮病或者健康。The pre-screening of cattle in the Shandong Province DHI database was carried out, and the DHI information was complete. 95 cattle with ketosis and 95 healthy cattle, a total of 190 cattle, these 190 cattle are evenly distributed in age and parity, and have been in the past. Within 7 to 14 days of the lactation period, at least two lactation periods have reported ketosis or health.
利用牛的尾椎静脉采血的方式,利用真空负压抗凝原理将牛的血液采集到5ml的真空采血管中。在牛产奶初期7到14天内,采用血酮仪对190头牛的 血液中β-羟丁酸浓度进行测定,吸取产奶初期奶牛一滴血液滴到与血酮仪配套的芯片试纸条上,插入血酮仪中,等待仪器分析计算10秒,读取血液中β-羟丁酸的浓度并做记录,测定实验重复两次。The blood is collected from the caudal vein of the cow, and the principle of vacuum negative pressure anticoagulation is used to collect the blood of the cow into a 5ml vacuum blood collection tube. During the first 7 to 14 days of milk production, the blood ketone meter was used to measure the concentration of β-hydroxybutyric acid in the blood of 190 cows, and a drop of blood from the cows at the early stage of milk production was dripped onto the chip test strip matched with the blood ketone meter. , Insert the blood ketone meter, wait for 10 seconds for the analysis and calculation of the instrument, read and record the concentration of β-hydroxybutyric acid in the blood, and repeat the measurement experiment twice.
2.采用Illumina BovineHD 150KSNP芯片进行基因分型2. Use Illumina BovineHD 150KSNP chip for genotyping
将190头牛血液DNA样品质量检测合格、滴定完成的血卡送到基因芯片测序公司,利用美国Illumina Bovine 150K基因芯片对190头牛的DNA进行基因分型和数据组装,以获得基因型数据。采用Plink 1.9软件对190头牛的150K基因芯片的数据进行质量控制,为保证填充参考基因芯片的基因型数据无缺失且分相,将基因型缺失率大于0的样本以及样本缺失率大于0的剔除掉。The blood cards of 190 cattle blood DNA samples qualified and titrated were sent to the gene chip sequencing company, and the DNA of 190 cattle was genotyped and data assembled using the American Illumina Bovine 150K gene chip to obtain genotype data. Use Plink 1.9 software to perform quality control on the 150K gene chip data of 190 cattle. To ensure that the genotype data filled in the reference gene chip are not missing and phased, samples with a genotype missing rate greater than 0 and samples with a sample missing rate greater than 0 Get rid of.
3.基因型填充3. Genotype filling
从NAGRP数据库下载Huang等人(2019)的包含2488头牛和50K SNP的与酮病有关的基因芯片数据。采用Fimpute和Beagle软件两步基因型填充法,以190头牛的150K基因芯片为参考,对NAGRP数据库中的2488头牛的50K基因芯片进行基因型填充。Download Huang et al.'s (2019) ketosis-related gene chip data containing 2488 cattle and 50K SNP from the NAGRP database. Using the two-step genotype filling method of Fimpute and Beagle software, with the 150K gene chip of 190 cattle as a reference, the 50K gene chip of 2488 cattle in the NAGRP database was used for genotype filling.
4.Fst、XPEHH、XPCLR基因组选择信号分析4. Fst, XPEHH, XPCLR genome selection signal analysis
将酮病组作为参考组,健康组作为实验组,即正向选择组。采用适用于疾病-对照正向选择信号分析的三种方法:Fst、XPEHH、XPCLR进行选择信号分析。采用Vcftool软件进行Fst的选择信号分析,计算Fst值;采用Selscan软件进行XPEHH正向选择信号分析;采用XPCLR软件进行XPCLR选择信号分析。The ketosis group was used as the reference group, and the healthy group was used as the experimental group, that is, the positive selection group. Three methods suitable for disease-control positive selection signal analysis: Fst, XPEHH, and XPCLR are used for selection signal analysis. Use Vcftool software for Fst selection signal analysis and calculate Fst value; use Selscan software for XPEHH forward selection signal analysis; use XPCLR software for XPCLR selection signal analysis.
5.GEMMA、PLINK全基因组关联分析5. GEMMA, PLINK genome-wide association analysis
以奶牛患酮病或健康二元性状为表型,利用GEMMA软件的一般线性模 型,对基因型填充后2678头牛的115787个标记进行了全基因组关联分析;以奶牛血液中β-羟丁酸含量作为表型,采用Plink软件的多元回归模型对190头牛的140668个标记进行全基因组关联分析。Taking dairy cows suffering from ketosis or healthy binary traits as the phenotype, using the general linear model of GEMMA software, a genome-wide association analysis was performed on 115787 markers of 2678 cows after genotype filling; β-hydroxybutyric acid in blood of dairy cows The content was used as the phenotype, and the genome-wide association analysis was performed on 140,668 markers of 190 cattle using the multiple regression model of Plink software.
6.受正选择遗传变异和候选基因的筛选6. Subject to positive selection genetic variation and candidate gene screening
利用Fst、XPCLR、XPEHH选择信号分析方法以及GEMMA、PLINK全基因组关联分析方法筛选和酮病相关的SNPs,以选择信号top 1%为阈值,P<0.05为全基因组关联分析的阈值,共筛选到和酮病抗性相关的候选基因98个,其中包括APOA1基因。Use Fst, XPCLR, XPEHH selection signal analysis methods and GEMMA, PLINK whole genome association analysis methods to screen SNPs related to ketosis, with the selection signal top 1% as the threshold, and P<0.05 as the threshold for the whole genome association analysis. There are 98 candidate genes related to ketosis resistance, including the APOA1 gene.
实施例2 牛酮病抗性基因APOA1中SNP的鉴定Example 2 Identification of SNP in the bovine ketosis resistance gene APOA1
1.APOA1基因在健康和酮病奶牛中的表达分析1. The expression analysis of APOA1 gene in healthy and ketotic dairy cows
利用荧光定量PCR,对健康和酮病奶牛血液样本进行定量检测,结果表明APOA1基因在患酮病奶牛中的表达水平显著高于在健康奶牛中的水平(P<0.05)。Quantitative detection of blood samples from healthy and ketotic dairy cows using fluorescent quantitative PCR showed that the expression level of APOA1 gene in ketotic dairy cows was significantly higher than that in healthy dairy cows (P<0.05).
2.牛酮病抗性基因APOA1的SNP测序鉴定2. SNP sequencing identification of bovine ketosis resistance gene APOA1
(1)选择健康牛95头,酮病牛95头,提取血液DNA。(1) Choose 95 healthy cattle and 95 ketosis cattle to extract blood DNA.
(2)对CPT1A基因5'侧翼区多态位点进行筛选。设计一对扩增引物:(2) Screen the polymorphic sites in the 5'flanking region of CPT1A gene. Design a pair of amplification primers:
F:5‘-CTCTGCTGCCTTTGTGAAG-3’(SEQ ID NO.1);F: 5'-CTCTGCTGCCTTTGTGAAG-3' (SEQ ID NO.1);
R:5‘-GCACCCTCTACTCACTCCAT-3’(SEQ ID NO.2)。R: 5'-GCACCCTCTACTCACTCCAT-3' (SEQ ID NO. 2).
随后进行PCR扩增,PCR产物经1%琼脂糖凝胶电泳检测。对扩增产物进行直接测序,发现APOA1在-572位点检测到一个SNP(g.-572A>G)。Subsequently, PCR amplification was performed, and the PCR products were detected by 1% agarose gel electrophoresis. Direct sequencing of the amplified product revealed that APOA1 detected a SNP at position -572 (g.-572A>G).
(3)采用SAS 9.4的最小二乘模型结合一般线性模型分析APOA1基因的SNP g.-572A>G与奶牛血液中β-羟丁酸含量的相关性,GG基因型奶牛血液中 β-羟丁酸浓度显著低于AA基因型。(3) Use SAS 9.4 least squares model combined with general linear model to analyze the correlation between SNP g.-572A>G of APOA1 gene and the content of β-hydroxybutyric acid in blood of dairy cows, and β-hydroxybutyrate in blood of dairy cows of GG genotype The acid concentration was significantly lower than the AA genotype.
实施例3 APOA1基因的不同基因型启动子活性的检测Example 3 Detection of promoter activity of different genotypes of APOA1 gene
为了进一步研究该启动子区域不同基因型个体的启动子活性,扩增APOA1基因长度为647bp的启动子片段,选取基因型为GG型和AA型的启动子片段,构建pGL3-basic-GG型和pGL3-basic-AA型的启动子载体并转染HepG2细胞,测定其荧光素酶活性。结果表明,APOA1基因GG型的启动子荧光素酶活性活性显著高于AA型个体的启动子活性(P<0.05)。In order to further study the promoter activity of individuals with different genotypes in the promoter region, a 647bp promoter fragment of the APOA1 gene was amplified, and promoter fragments with genotypes of GG and AA were selected to construct pGL3-basic-GG and The promoter vector of pGL3-basic-AA type was transfected into HepG2 cells, and its luciferase activity was measured. The results showed that the luciferase activity of the GG type promoter of APOA1 gene was significantly higher than that of the AA type individual (P<0.05).
应注意的是,以上实例仅用于说明本发明的技术方案而非对其进行限制。尽管参照所给出的实例对本发明进行了详细说明,但是本领域的普通技术人员可根据需要对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的精神和范围。It should be noted that the above examples are only used to illustrate the technical solutions of the present invention rather than limiting them. Although the present invention has been described in detail with reference to the given examples, those of ordinary skill in the art can modify or equivalently replace the technical solutions of the present invention as needed without departing from the spirit and scope of the technical solutions of the present invention.

Claims (10)

  1. 一种筛选奶牛酮病抗性基因的方法,其特征在于,所述方法至少包括:A method for screening dairy cattle ketosis resistance genes, characterized in that the method at least comprises:
    基于SNP芯片检测分析健康奶牛和患酮病奶牛DNA样品;Analyze DNA samples of healthy cows and cows suffering from ketosis based on SNP chip detection;
    基于Fst、XPCLR和XPEHH基因组选择信号分析方法和GEMMA、PLINK全基因组关联分析方法进行分析;筛选受到显著正选择和与酮病显著相关的单核苷酸多态SNPs以及候选基因,整合基因功能注释筛选酮病抗性的SNP分子标记。Analysis based on Fst, XPCLR and XPEHH genome selection signal analysis methods and GEMMA and PLINK genome-wide association analysis methods; screening SNPs and candidate genes that are significantly positively selected and significantly associated with ketosis, and integrate gene function annotations Screen SNP molecular markers for ketosis resistance.
  2. 如权利要求1所述的方法,其特征在于,所述方法包括:The method of claim 1, wherein the method comprises:
    S1.健康奶牛和患酮病奶牛样品的采集及DNA提取;S1. Collection and DNA extraction of samples from healthy cows and cows suffering from ketosis;
    S2.SNP芯片检测分析;S2. SNP chip detection and analysis;
    S3.基因型填充;S3. Genotype filling;
    S4.Fst、XPCLR、XPEHH基因组选择信号分析;S4. Fst, XPCLR, XPEHH genome selection signal analysis;
    S5.GEMMA、PLINK全基因组关联分析;S5. GEMMA, PLINK genome-wide association analysis;
    S6.基于候选基因的筛选策略筛选候选基因;S6. Screening candidate genes based on the screening strategy of candidate genes;
    S7.鉴定位于候选基因内受选择的SNPs;S7. Identify selected SNPs located in candidate genes;
    其中,步骤S4与S5没有先后顺序之分。Among them, steps S4 and S5 are in no order.
  3. 如权利要求2所述的方法,其特征在于,步骤S1具体方法包括:The method according to claim 2, wherein the specific method of step S1 comprises:
    S1.1对奶牛血液中β-羟丁酸浓度进行测定;S1.1 Determine the concentration of β-hydroxybutyric acid in the blood of dairy cows;
    S1.2采集健康奶牛和患酮病奶牛的血液,提取血液组织中的DNA。S1.2 Collect blood from healthy cows and cows suffering from ketosis, and extract DNA from blood tissues.
  4. 如权利要求2所述的方法,其特征在于,步骤S2具体方法包括:The method according to claim 2, wherein the specific method of step S2 includes:
    S2.1使用SNP芯片对DNA样品进行分析,并进行基因分型;S2.1 Use SNP chips to analyze DNA samples and perform genotyping;
    S2.2对SNP数据进行过滤,对剩余符合要求的SNP做进一步分析;S2.2 Filter the SNP data, and further analyze the remaining SNPs that meet the requirements;
    S2.3为每条染色体构建单倍型;S2.3 constructs a haplotype for each chromosome;
    S2.4获取数据库中50K基因芯片数据;S2.4 Obtain 50K gene chip data in the database;
    S2.5以150K基因芯片为参考,对50K基因芯片数据进行基因型填充。S2.5 uses the 150K gene chip as a reference to fill in the genotype of the 50K gene chip data.
  5. 如权利要求2所述的方法,其特征在于,步骤S3具体方法包括:The method according to claim 2, wherein the specific method of step S3 includes:
    S3.1选择信号Fst和hapFLK基因组扫描和局部进化树的构建:对奶牛品种获得的所有数据进行Fst分析;S3.1 Selection signal Fst and hapFLK genome scanning and local evolutionary tree construction: Fst analysis of all data obtained by dairy cow breeds;
    S3.2估算患酮病奶牛和健康奶牛品种之间的XPCLR值;S3.2 Estimate the XPCLR value between ketosis cows and healthy cow breeds;
    S3.3估算患酮病奶牛和健康奶牛品种之间的XPEHH值。S3.3 Estimate the XPEHH value between ketosis cows and healthy cow breeds.
  6. 如权利要求2所述的方法,其特征在于,步骤S4具体方法包括:The method according to claim 2, wherein the specific method of step S4 comprises:
    S4.1采用GEMMA单变量线性混合模型,以奶牛患酮病或健康二元性状为表型进行全基因组关联分析;S4.1 uses GEMMA univariate linear mixed model to conduct genome-wide association analysis with dairy cows suffering from ketosis or healthy binary traits as the phenotype;
    S4.2以奶牛血液中β-羟丁酸含量作为表型,利用多元回归模型,以奶牛的胎次、年龄为协变量进行全基因组关联分析;S4.2 Take the content of β-hydroxybutyric acid in the blood of dairy cows as the phenotype, use the multiple regression model, and use the parity and age of the dairy cows as covariates to conduct genome-wide association analysis;
    S4.3基于Benjamini和Hochberg校正方法计算显著性的P值;S4.3 Calculate the significance P value based on the Benjamini and Hochberg correction method;
    S4.4生成GWAS分析的曼哈顿图;S4.4 Generate Manhattan chart of GWAS analysis;
    S4.5 SNP注释通过Bedtools在UCSC数据库中检索。S4.5 SNP annotations are retrieved in the UCSC database through Bedtools.
  7. 如权利要求2所述的方法,其特征在于,步骤S5具体方法包括:The method according to claim 2, wherein the specific method of step S5 comprises:
    S5.1选择具有Fst、XPCLR或XPEHH中有强选择信号和最显著P值的SNPs;S5.1 Select SNPs with strong selection signal and the most significant P value among Fst, XPCLR or XPEHH;
    S5.2使用UCSC基因组浏览器检索由SNP定义的每个选定区域内的带注释的Refseq基因;S5.2 Use the UCSC genome browser to search for the annotated Refseq genes in each selected region defined by the SNP;
    S5.3选用每种分析方法所得出的信号值排名前1%的SNP标记定位受 选择的SNPs,将基因限定在每个显著SNP上下游500K bp以内,定位受正选择的基因;筛选出同时在至少有2种分析方法同时鉴定到的基因,并且至少在一种分析方法中,其选择信号值或者显著性检验的P值排名前10,作为重要候选基因;S5.3 Select the top 1% SNP markers with the signal value obtained by each analysis method to locate the selected SNPs, limit the genes to within 500K bp upstream and downstream of each significant SNP, locate the positively selected genes; screen out simultaneous Genes identified by at least two analysis methods at the same time, and in at least one analysis method, the selected signal value or the P value of the significance test ranks the top 10 as important candidate genes;
    S5.4应用DVAID对筛选到的候选基因进行功能分析,并应用Benjamini-Hochberg进行多重校正,分析基因富集在哪些特定的分子功能以及细胞成分或者生物学通路中。S5.4 Use DVAID to perform functional analysis on the selected candidate genes, and apply Benjamini-Hochberg to perform multiple corrections to analyze which specific molecular functions and cellular components or biological pathways the genes are enriched in.
  8. 如权利要求2所述的方法,其特征在于,步骤S6具体方法包括:The method according to claim 2, wherein the specific method of step S6 comprises:
    S6.1确定候选基因,鉴定出位于候选基因受选择的SNPs;S6.1 Determine candidate genes and identify SNPs located in candidate genes that are selected;
    S6.2对鉴定出的SNPs与奶牛酮病做相关性分析。S6.2 Perform correlation analysis on the identified SNPs and ketosis in dairy cows.
  9. 如权利要求2所述的方法,其特征在于,所述奶牛酮病抗性候选基因包括APOA1;SNP位点为g.-572 A>G。The method of claim 2, wherein the candidate genes for ketosis resistance in dairy cows include APOA1; and the SNP locus is g.-572 A>G.
  10. 权利要求1-9任一项所述方法在如下1)-9)中任一种中的应用:The application of the method according to any one of claims 1-9 in any one of the following 1)-9):
    1)鉴定或辅助鉴定待测奶牛的酮病抗性;1) Identify or assist in the identification of ketosis resistance of the cows to be tested;
    2)制备鉴定或辅助鉴定待测奶牛的酮病抗性的产品;2) Preparation of products to identify or assist in identifying the ketosis resistance of the cows to be tested;
    3)鉴定或辅助鉴定待测奶牛为酮病抗性奶牛;3) Identify or assist in identifying the cows to be tested as ketosis-resistant cows;
    4)制备鉴定或辅助鉴定待测奶牛为酮病抗性奶牛的产品;4) Preparation of products to identify or assist in identifying the cows to be tested as ketosis-resistant cows;
    5)奶牛选育;5) Breeding of dairy cows;
    6)选育奶牛酮病抗性品种;6) Breeding breeds resistant to ketosis in dairy cows;
    7)制备选育奶牛酮病抗性品种的产品;7) Preparation of products for breeding ketosis-resistant varieties of dairy cows;
    8)鉴定或辅助鉴定待测奶牛的酮病抗性性状;8) Identify or assist in identifying the ketosis resistance traits of the cows to be tested;
    9)制备鉴定或辅助鉴定奶牛的酮病抗性性状的产品;9) Preparation of products to identify or assist in the identification of ketosis resistance traits of dairy cows;
    优选的,所述应用方式包括:Preferably, the application method includes:
    提取不同奶牛个体的血液DNA;Extract blood DNA from different individual cows;
    鉴定带有酮病抗性分子标记的个体;Identify individuals with molecular markers of ketosis resistance;
    进一步优选的,所述分子标记为g.-572 A>G;Further preferably, the molecular label is g.-572 A>G;
    扩增含分子标记基因片段的引物包括SEQ ID NO.1和SEQ ID NO.2。The primers for amplifying gene fragments containing molecular markers include SEQ ID NO.1 and SEQ ID NO.2.
PCT/CN2020/126281 2020-06-09 2020-11-03 Method for screening ketosis-resistant molecular markers of dairy cows and application thereof WO2021248793A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010517904.7A CN111485027B (en) 2020-06-09 2020-06-09 Method for screening dairy cow ketosis resistance molecular marker and application thereof
CN202010517904.7 2020-06-09

Publications (1)

Publication Number Publication Date
WO2021248793A1 true WO2021248793A1 (en) 2021-12-16

Family

ID=71813514

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/126281 WO2021248793A1 (en) 2020-06-09 2020-11-03 Method for screening ketosis-resistant molecular markers of dairy cows and application thereof

Country Status (2)

Country Link
CN (1) CN111485027B (en)
WO (1) WO2021248793A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111485027B (en) * 2020-06-09 2022-07-29 山东省农业科学院奶牛研究中心 Method for screening dairy cow ketosis resistance molecular marker and application thereof
CN113416789B (en) * 2021-07-27 2022-06-03 山东省农业科学院畜牧兽医研究所 Molecular marker related to concentration of beta-hydroxybutyric acid in milk cow blood and application thereof
CN113774154B (en) * 2021-10-26 2023-09-22 山东省农业科学院畜牧兽医研究所 Method for screening bovine body high mutation related molecular marker and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017058897A1 (en) * 2015-09-28 2017-04-06 Brigham Young University Lipodomic biomarkers of metabolic diseases in dairy cows
CN109680078A (en) * 2019-02-22 2019-04-26 华中农业大学 Utilize the method for SNP site selection signal change of gradient Index Assessment economic characters candidate gene
CN109994153A (en) * 2019-04-09 2019-07-09 山东省农业科学院奶牛研究中心 A kind of method and its application for screening ox high altitude hypoxia adaptation molecular labeling
CN110106250A (en) * 2019-05-28 2019-08-09 中国农业大学 Molecular labeling relevant to cow in perinatal period metabolic disease resistance and application
CN111485027A (en) * 2020-06-09 2020-08-04 山东省农业科学院奶牛研究中心 Method for screening dairy cow ketosis resistance molecular marker and application thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017058897A1 (en) * 2015-09-28 2017-04-06 Brigham Young University Lipodomic biomarkers of metabolic diseases in dairy cows
CN109680078A (en) * 2019-02-22 2019-04-26 华中农业大学 Utilize the method for SNP site selection signal change of gradient Index Assessment economic characters candidate gene
CN109994153A (en) * 2019-04-09 2019-07-09 山东省农业科学院奶牛研究中心 A kind of method and its application for screening ox high altitude hypoxia adaptation molecular labeling
CN110106250A (en) * 2019-05-28 2019-08-09 中国农业大学 Molecular labeling relevant to cow in perinatal period metabolic disease resistance and application
CN111485027A (en) * 2020-06-09 2020-08-04 山东省农业科学院奶牛研究中心 Method for screening dairy cow ketosis resistance molecular marker and application thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BAI, JIACHEN: "Selection Signature Analysis and Gene Function Verification for Ketosis Resistance in Chinese Holstein Cattle", AGRICULTURE, CHINA MASTER’S THESES FULL-TEXT DATABASE, 15 August 2020 (2020-08-15), pages 1 - 84, XP009532755 *
HUANG H., J CAO, Q HANIF, Y WANG, Y YU, S ZHANG, Y ZHANG : "Genome-wide association study identifies energy metabolism genes for resistance to ketosis in Chinese Holstein cattle", INTERNATIONAL FOUNDATION FOR ANIMAL GENETICS, vol. 50, 31 December 2019 (2019-12-31), XP055878255, DOI: 10.1111/age.12802 *
MAHMOUDI AHMAD, AMIR ZARGARAN, HAMID-REZA AMINI, ASSAD ASSADI, REZA VAJDI HOKMABAD, SHAHIN EGHBALSAIED : "A SNP in the 3′-untranslated region of AMPKγ1 may associate with serum ketone body and milk production of Holstein dairy cows", GENE, vol. 574, 27 July 2015 (2015-07-27), pages 48 - 52, XP055878251, DOI: 10.1016/j.gene.2015.07.077 *
YANG LING, JIACHEN BAI, ZHIHUA JU, QIANG JIANG, JINPENG WANG, YAPING GAO, YARAN ZHANG, XIAOCHAO WEI, JINMING HUANG: "Effect of functional single nucleotide polymorphism g.-572 A > G of apolipoprotein A1 gene on resistance to ketosis in Chinese Holstein cows", RESEARCH IN VETERINARY SCIENCE, vol. 135, 20 October 2020 (2020-10-20), pages 310 - 316, XP055878249, DOI: 10.1016/j.rvsc.2020.10.006 *

Also Published As

Publication number Publication date
CN111485027B (en) 2022-07-29
CN111485027A (en) 2020-08-04

Similar Documents

Publication Publication Date Title
WO2021248793A1 (en) Method for screening ketosis-resistant molecular markers of dairy cows and application thereof
US20090269741A1 (en) Method for assessing traits selected from longissimus dorsi peak force, intramuscular fat, retail beef yield and net feed intake in bovine animals
CN107058538B (en) Primer composition, kit composed of primer composition and application of kit
CN112652362B (en) Method for screening bovine plateau hypoxia adaptive gene ALDOC and functional molecular marker and application thereof
CN103290123B (en) Detecting method and kit of cattle IGF2 (Insulin-like Growth Factor 2) gene mononucleotide polymorphism
CN112662788A (en) SNP marker related to Chinese southern Holstein cow milk production traits and application thereof
CN112899373B (en) SNP (Single nucleotide polymorphism) marker related to milk fat percentage of southern Holstein cows in China and application thereof
Abdel-Shafy et al. Prospecting genomic regions associated with milk production traits in Egyptian buffalo
CN111518896A (en) Primer group, application, product and method for detecting nicotine dependence related SNP site
CN110079613A (en) The molecular labeling and detection method of Holstein cow heat stress tolerance
Fuku et al. Exceptional longevity and muscle and fitness related genotypes: a functional in vitro analysis and case-control association replication study with SNPs THRH rs7832552, IL6 rs1800795, and ACSL1 rs6552828
CN108998543A (en) A kind of SNP marker relevant to swine erythrocyte number character
KR101289576B1 (en) Development of molecular marker related to meat quantity in Hanwoo
CN106957907B (en) Genetic test for liver copper accumulation in dogs
CN102732625B (en) Bovine leukocyte adhesion deficiency (BLAD) pyrosequencing detection method
CN110863044A (en) Primer combination for detecting VCL gene mutation and application thereof
CN113416789B (en) Molecular marker related to concentration of beta-hydroxybutyric acid in milk cow blood and application thereof
CN104313030B (en) SNP marker of porcine interferon alpha and application
CN114480614B (en) Primer set and kit for detecting HLA-DQ alpha 1:160D coding genes
CN114717336B (en) Molecular marker related to sheep viscera weight and application thereof
CN113718025B (en) SNP kit for diabetic retinopathy gene detection based on KASP
CN106755449B (en) SNP molecular marker related to porcine cytokine IFN gamma and preparation method thereof
CN116042855A (en) Bactrian camel milk production property related gene EVX2 and application thereof as molecular marker
CN116083600A (en) Bactrian camel milk fat percentage related gene CARD11 and application thereof as molecular marker
CN114150073A (en) SNPs (single nucleotide polymorphisms) marker for detecting milk production traits of dairy cows and application

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20940425

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20940425

Country of ref document: EP

Kind code of ref document: A1